• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

Article

January 27, 2023

Study Results Show Link Between Moderate or Vigorous Physical Activity and Brain Power

Author(s):

Ashley Gallagher, Editor

When replaced with just 6 to 7 minutes daily of light-intensity exercise or sedentary behavior, data show poorer cognitive performance.

The time spent in moderate and vigorous physical activity (MVPA) every day is linked to mid-life brain power, according to the results of a study published online in the Journal of Epidemiology & Community Health.

Investigators saw that these intensity levels were best for working memory and mental processes, including organization and planning. When replaced with 6 to 7 minutes of light-intensity activity or sedentary behavior every day, investigators found it was associated with poorer cognitive performance.

In other studies, MVPA was linked to health. However, investigators did not include time spent asleep. Investigators in this study adopted a compositional approach to see if MVPA was relative to all other daily movement behaviors for mid-life cognitive performance.

Investigators gathered data from individuals in the 1970 British Cohort Study, which comprised individuals born in England, Scotland, and Wales in 1970 whose health was tracked throughout their life. From 2016 to 2018, 8581 individuals, aged 46 to 47 years, were asked to fill in detailed background, health, and lifestyles questionnaires, and to wear an activity tracker for up to 7 days and for at least 10 consecutive hours a day.

Participants took cognitive tests for executive function, which included processing accuracy and speed and verbal fluency delayed and immediate word recall tasks. The scores for each test were totaled to produce an overall global score for both categories.

For those who wore the activity tracker, 2959 individuals were excluded because of device errors, insufficient wear time, or failing to complete the questionnaires.

The analysis of the activity tracker data showed that individuals had an average of 5 hours and 42 minutes of light intensity and physical activity, 51 minutes of MVPA, 9 hours and 16 minutes of sedentary behaviors, and 8 hours and 11 minutes of sleep over a 24-hour period.

The time spent in MVPA relative to other types of behavior was positively associated with cognitive performance after adjusting for educational attainment and workplace physical activity. However adjustments for health issues wakened the associations.

Sedentary behavior relative to light physical activity and sleep were also positively associated with cognitive performance, which investigators said could be linked to greater engagement in cognitive stimulating activities, such as reading or working.

They also found that the associations were stronger for executive function than for memory.

Additionally, individuals in the upper half of cognitive performance scores had more time in MVPA and sedentary behaviors and less time sleeping, Individuals in the lowest 25% of scorers had the most light-intensity physical activity.

Investigators reallocated time from 1 component to another, minute by minute, to estimate the impact joint associations that movement and cognition could have on global cognitive performance scores. They found that there were increases in scores after MVPA displaced other activities.

Cognition showed a 1.31% improvement in ranking compared with the sample average improvement after as little as 9 minutes of sedentary activities was replaced with more vigorous activities.

Furthermore, there was a 1.27% improvement from replacing gentle activities or 1.2% from replacing 7 minutes of sleep. The improvements increased with greater exchanges of time.

Sedentary behavior also increased cognition scores. However, it was only beneficial when substituting it for 37 minutes of light-intensity physical activity or 56 minutes of sleep.

Participants’ cognition rankings also declined by 1% to 2% after just 8 minutes of more vigorous activity was replaced by sedentary activities and continued to decline with greater declines in MVPA.

Reference

Mid-life moderate + vigorous physical activity quota associated with brain power. EurekAlert. News release. January 23, 2023. Accessed January 24, 2023. https://www.eurekalert.org/news-releases/977165

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Pharmacist and doctor -- Image credit: ake1150 | stock.adobe.com
Pharmacist and patient -- Image credit: Zamrznuti tonovi | stock.adobe.com
Related Content
Advertisement
After the Approval: Assessing RSV Vaccine Safety in Older Adults and Pregnant Patients
August 15th 2025

After the Approval: Assessing RSV Vaccine Safety in Older Adults and Pregnant Patients

Monica Holmberg, PharmD, BCPS
Pharmacy Times, Pharmacy Focus Oncology Edition
August 15th 2025

Taletrectinib Takes Aim: A New Chapter in ROS1-Positive NSCLC

Alexandra Gerlach, Associate Editor Kevin Chen, PharmD Amanda Cass, PharmD, BCPS, BCOP
Sickle cell disease (SCD) -- Image credit: tussik | stock.adobe.com
August 15th 2025

BEAM-101 Receives RMAT for the Treatment of Sickle Cell Disease

Gillian McGovern, Associate Editor
A Roundtable Discussion of Upcoming Hot Line Trials at ESC Congress 2025
August 15th 2025

A Roundtable Discussion of Upcoming Hot Line Trials at ESC Congress 2025

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP
Patient Perceptions Support Co-Management of Chronic Kidney Disease
August 15th 2025

Patient Perceptions Support Co-Management of Chronic Kidney Disease

Helen Pervanas, PharmD
Research Underscores the Critical Role of Pharmacists in Managing Stiff Person Syndrome
August 15th 2025

Research Underscores the Critical Role of Pharmacists in Managing Stiff Person Syndrome

Cortney Steward. PharmD Candidate Kyla Ellis, PharmD Candidate Madison Holmes, PharmD, BCPS
Related Content
Advertisement
After the Approval: Assessing RSV Vaccine Safety in Older Adults and Pregnant Patients
August 15th 2025

After the Approval: Assessing RSV Vaccine Safety in Older Adults and Pregnant Patients

Monica Holmberg, PharmD, BCPS
Pharmacy Times, Pharmacy Focus Oncology Edition
August 15th 2025

Taletrectinib Takes Aim: A New Chapter in ROS1-Positive NSCLC

Alexandra Gerlach, Associate Editor Kevin Chen, PharmD Amanda Cass, PharmD, BCPS, BCOP
Sickle cell disease (SCD) -- Image credit: tussik | stock.adobe.com
August 15th 2025

BEAM-101 Receives RMAT for the Treatment of Sickle Cell Disease

Gillian McGovern, Associate Editor
A Roundtable Discussion of Upcoming Hot Line Trials at ESC Congress 2025
August 15th 2025

A Roundtable Discussion of Upcoming Hot Line Trials at ESC Congress 2025

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP
Patient Perceptions Support Co-Management of Chronic Kidney Disease
August 15th 2025

Patient Perceptions Support Co-Management of Chronic Kidney Disease

Helen Pervanas, PharmD
Research Underscores the Critical Role of Pharmacists in Managing Stiff Person Syndrome
August 15th 2025

Research Underscores the Critical Role of Pharmacists in Managing Stiff Person Syndrome

Cortney Steward. PharmD Candidate Kyla Ellis, PharmD Candidate Madison Holmes, PharmD, BCPS
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.